11 July 2025
Kia ora, In this issue Insights from our Executive Director We are all acutely aware of how tough things are, but the biotech sector never ceases to amaze me. There … Continue reading "Tru-Test names Simon Mander as new chief executive"
Read More
10 July 2025
New Zealand has the research excellence, innovation mindset, and community strength to compete globally. Now is the time to: Let’s take inspiration from global leaders and shape a bold, connected, … Continue reading "Tru-Test names Simon Mander as new chief executive"
Read More
29 May 2025
Our new Executive Council has been focused on enhancing member value, ensuring you receive maximum benefit from your membership while we deliver what matters most to you.
Read More
18 March 2025
In this issue Insights from our Executive Director Reflecting on our journey from 2017—when NZBIO faced financial challenges and joined the NZTech Group—to today is truly remarkable. Four years of … Continue reading "Tru-Test names Simon Mander as new chief executive"
Read More
12 February 2025
In this issue Insights from our Executive Director As we kick off the year, BioTechNZ is already moving full speed ahead with exciting developments in the biotech sector. There is … Continue reading "Tru-Test names Simon Mander as new chief executive"
Read More
16 December 2024
It has been a landmark year for BioTechNZ and our members. Let's take a moment to reflect on the progress and achievements of 2024!
Read More
30 September 2024
Kia ora, In this issue Insights from our Executive Director The more I work in this role the more excited I am about the convergence of once-siloed technologies across multidisciplinary … Continue reading "Tru-Test names Simon Mander as new chief executive"
Read More
03 September 2024
In this issue Insights from our Executive Director During the last month there has been plenty of discussion in the media regarding gene technologies – should our companies and researchers … Continue reading "Tru-Test names Simon Mander as new chief executive"
Read More
02 September 2024
We can’t wait to reconnect at Aotearoa New Zealand’s 2025 Life Science Summit – Uniting biology and technology to unleash potential. 18-19 March, 2025 at Tākina Wellington Convention and Exhibition Centre. Click here … Continue reading "Tru-Test names Simon Mander as new chief executive"
Read More
21 June 2024
It has been another busy month for biotech. More than 35 Kiwis travelled to the BIO International Convention in San Diego.
Read More
06 March 2024
In this issue Insights from our Executive Director This year feels like it’s going to be a fast game, but a good game for the biotech sector! I am incredibly … Continue reading "Tru-Test names Simon Mander as new chief executive"
Read More
Tru-Test Corp has hired Simon Mander to lead the agritech company as it looks to build earnings after a hard round of cost-cutting in response to last year’s dairy downturn. Mander started at the Auckland-based company today, replacing Greg Muir who stepped down after more than eight years in t
September 11, 2017
Twenty years ago this week, husband and wife Dr Hartley Atkinson and Marree Atkinson, started AFT Pharmaceuticals (AFT) in a room off their home garage. Last year the NZX and ASX listed company earned revenue of NZ$70M and has a market capitalisation of around NZ$250M. Reflecting on 20 years in
August 31, 2017
Upside Biotechnologies appoints leading US life sciences executive to Board Regenerative medicine start-up, Upside Biotechnologies, has appointed Boston-based Dr Daniel R. Marshak Ph.D. to its Board. New Zealand-based Upside is developing an advanced, world-class skin replacement treatment for p
August 23, 2017
The New Zealand Government announced an investment of up to NZ$35 million over seven years in Genomics Aotearoa (GA), a new collaborative science organisation supporting advanced genomics research. Genomics Aotearoa is an alliance led by the University of Otago and includes the Universities
August 21, 2017
A trial for the treatment for deadly peanut allergy at the Murdoch Children’s Research Institute (MCRI) has shown the strongest evidence yet that a cure may be possible. At the end of the original trial in 2013, 82% of children who received the oral immunotherapy were deemed tolerant to peanuts
August 17, 2017
Monsanto Company (NYSE: MON) and ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, announced today that the companies have reached a global licensing agreement for the use of ToolGen's CRISPR technology platform to develop agricultural products. ToolGen is an
August 17, 2017
FOR bovine reproduction expert Luiz Porto it’s all about producing better beef. The Brazilian trained vet said that’s achieved by taking the genetics of the best performing animals and by using In Vitro Fertilisation (IVF), rapidly decreasing the interval generation t
August 16, 2017
Tech Futures Lab and The Mind Lab by Unitec have expanded the depth and breadth of their team with three key additions. Louise Webster, Craig Hilton and Lorraine Guerin will help to deliver new initiatives including ‘Driving Innovation’ (as an Approved Supplier of Callaghan Innovation) and an
August 16, 2017
The growth of our technology-based exporters can be accelerated by making changes to the way our science and innovation system operates. Richard Bentley in his book Innovate! Transforming New Zealand’s technology - based economy, launched yesterday, presents a review of the state of our technolo
August 16, 2017